New article fully published in our journal: "Engineering a novel light-chain single-domain antibody to enable IgG-format bispecific antibody design" by authors from Fudan University in Shanghai, China. Congratulations.

doi.org/10.1093/abt/...

#Bispecific #LightChainSingleDomainAntibody

New article fully published in our journal: "Generation and characterization of novel high-affinity fully human antibodies targeting prostate-specific membrane antigen and prostatic acid phosphatase" by authors from Philochem and Philogen in Switzerland. Congratulations!

doi.org/10.1093/abt/...

Here is an interesting paper by my friend Diana Liu, in collaboration with one of my favorite mass spec software company Protein Metrics.

doi.org/10.1016/j.ta...

Automation streamlines peptide map preparation, analysis and reporting for biotherapeutic antibody characterization

This practical advise review article, published earlier this year, has already been cited 8 times. It will be part of the formulation special collection our journal will launch next week.

doi.org/10.1093/abt/...

#Review #Lyo #Formulation #Practical

I would like to highlight this high impact review article. Since publication just a few months ago, it has been cited multiple times , and downloaded over 16,000 times.

If you are interested in ADCs, this one is a must read!

#ADC #Conjugation #Review

doi.org/10.1093/abt/...

New review article on our journal: Reprogramming the tumor microenvironment: synergistic mechanisms of antibody–drug conjugates and immune checkpoint inhibitors

doi.org/10.1093/abt/...

#OpenAccess #ADC #ICI #TME #irAE #IMER #Oncology

I am happy to announce that we have selected the cover image of volume 8 issue 3, based on Dr. William Strohl's excellent review of 2024 FDA Approved Antibody Therapeutics. See the full article here: doi.org/10.1093/abt/...

Congratulations, Dr. Strohl, and thank you as always!!